par 513 Pill - white oval, 13mm
Pill with imprint par 513 is White, Oval and has been identified as Minocycline Hydrochloride 100 mg. It is supplied by Par Pharmaceutical Inc.
Minocycline is used in the treatment of Acne; Bacterial Infection; Bartonellosis; Actinomycosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par 513
Minocycline Hydrochloride
- Imprint
- par 513
- Strength
- 100 mg
- Color
- White
- Size
- 13.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Inc.
- Inactive Ingredients
-
lactose anhydrous,
microcrystalline cellulose,
sodium starch glycolate type A potato,
magnesium stearate,
titanium dioxide,
polyethylene glycol 400,
polysorbate 80,
silicon dioxide,
povidone k30
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 49884-0513 | Par Pharmaceutical, Inc. |
| 42291-0591 | AvKare, Inc. |
| 60429-0335 | Golden State Medical Supply (repackager) |
Related images for "par 513"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (562)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline (Oral) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Dynacin, Solodyn, Minolira, ... +2 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Solodyn, Minocin for Injection, Minolira, Ximino
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
